Tumor endothelial marker 7 (TEM-7): A novel target for antiangiogenic therapy

Microvascular Research

Volumn 82, Issue 3, 2011, Pages 253-262

  Bagley, Rebecca G ^a   Rouleau, Cecile ^a   Weber, William ^a   Mehraein, Khodadad ^b   Smale, Robert ^b   Curiel, Maritza ^b   Callahan, Michelle ^a   Roy, Andre ^a   Boutin, Paula ^a   Martin, Thia St ^a   Nacht, Mariana ^a   Teicher, Beverly A ^a  

^a GENZYME CORPORATION   (United States)

^b GENZYME GENETICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; MESSENGER RNA; PARAFFIN; TUMOR ENDOTHELIAL MARKER 7; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTIANGIOGENIC THERAPY; ARTICLE; BLADDER CANCER; BREAST CARCINOMA; CANCER DIAGNOSIS; CELL MEDIATED CYTOTOXICITY; COLON CANCER; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; LUNG CANCER; MALE; MARKER GENE; MICROVASCULAR ENDOTHELIAL CELL; OVARY CARCINOMA; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SARCOMA; TUMOR ENDOTHELIAL MARKER 7 GENE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FORMALDEHYDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEOPLASM PROTEINS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PARAFFIN EMBEDDING; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TISSUE FIXATION; TRANSFECTION;

ADENOVIRIDAE;

EID: 81055156003     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.09.004     Document Type: Article

References (43)

1. Ammer A.G., Weed S.A. Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil. Cytoskeleton 2008, 65:687-707.
2. Bagley R.G., et al. Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells. Cancer Res. 2003, 63:5866-5873.
3. Bagley R.G., et al. Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int. J. Oncol. 2009, 34:619-627.
4. Bagley R.G., et al. Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248. Mol. Cancer Ther. 2008, 7:2536-2546.
5. Bagley R.G., et al. Human pericytes from developing and malignant tissues express endosialin/tumor endothelial marker 1. Microvasc. Res. 2008, 76:180-188.
6. Beaty R.M., et al. PLXDC1 (TEM7) is identified in a genome-wide expression screen of glioblastoma endothelium. J. Neurooncol. 2007, 81:241-248.
7. Bexell D., et al. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol. Ther. 2009, 17:183-190.
8. Bourboulia D., Stetler-Stevenson W.G. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin. Cancer Biol. 2010, 20:161-168.
9. Carson-Walter E.B., et al. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res. 2001, 61:6649-6655.
10. Cater P.J., Senter P.D. Antibody-drug conjugates for cancer therapy. Cancer J. 2008, 14:154-169.
11. Chizea J.P., et al. Endothelial progenitor cells significantly contribute to vasculatures in human and mouse breast tumors. Open Hem. J. 2008, 1:3-62.
12. Chouaib S., et al. Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells. Crit. Rev. Immunol. 2010, 30:529-545.
13. Conejo-Garcia J.R., et al. Vascular leukocytes contribute to tumor vascularization. Blood 2005, 105:679-681.
14. Cook K.M., Figg W.D. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J. Clin. 2010, 60:222-243.
15. D'Amico F., et al. State of the art in antigen retrieval for immunohistochemistry. J. Immunol. Methods 2009, 341:1-18.
16. Davies G., et al. Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin. Exp. Metastasis 2004, 21:31-37.
17. Escorcio-Correia M., Hagemann T. Macrophages in the tumor microenvironment. The Tumor Microenvironment 2010, 371-384. Springer, New York, NY. R.G. Bagley, B.A. Teicher (Eds.).
18. Fang S., Salven P. Stem cells in tumor angiogenesis. J. Mol. Cell. Cardiol. 2011, 50:290-295.
19. Fuchs B., et al. High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Gene 2007, 399:137-143.
20. Gao D., et al. Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim. Biophys. Acta 2009, 1796(1):33-40.
21. Gaulteir A., et al. LDL receptor-related protein 1 regulates the abundance of diverse cell-signaling proteins in the plasma membrane proteome. J. Prot. Res. 2010, 9:6689-6695.
22. Han H.D., et al. Targeted gene silencing using RGD-labeled chitosan nanoparticles. Clin. Cancer Res. 2010, 2010(16):3910-3922.
23. Ho M.S., et al. Nidogens: extracellular matrix linker molecules. Microvasc. Res. Technol. 2008, 71:387-395.
24. Keyes K.A., et al. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex multiplex technology. Cancer Chemother. Pharmacol. 2003, 51:321-327.
25. Kruegel J., Miosge N. Basement membrane components are key players in specialized extracellular matrices. Cell. Mol. Life Sci. 2010, 67:2879-2895.
26. Lambert J.M. Drug-conjugated monoclonal antibodies for the treatment of cancer. Curr. Opin. Pharmacol. 2005, 5:543-549.
27. Lee H.K., et al. Cloning, characterization and neuronal expression profiles of tumor endothelial marker 7 in the rat brain. Brain Res. Mol. Brain Res. 2005, 136:189-198.
28. Lee H.K., et al. Identification of the basement membrane protein nidogen as a candidate ligand for tumor endothelial marker 7 in vitro and in vivo. FEBS Lett. 2006, 580:2253-2257.
29. Lee H.K., et al. Expression of tumor endothelial marker 7 mRNA and protein expression in the dorsal rat ganglion neurons of the rat. Neurosci. Lett. 2006, 402:71-75.
30. Lindquist J.N., et al. Derivation of vasculature from embryonic stem cells. Curr. Prot. Stem Cell Biol. 2010, 12. 1F9.1-1F9.6.
31. McCall A.M., et al. Increasing the affinity for tumor antigen enhances bispecific antibody cytotoxicity. J. Immunol. 2001, 166:6112-6117.
32. Meehan B., et al. Age-related properties of the tumour vasculature in renal cell carcinoma. BJU Int. 2010, 107:416-424.
33. Miller S.F.K., et al. Expression of Plxdc2/TEM7R in the developing nervous system of the mouse. Gene Expr. Patterns 2007, 7:635-644.
34. Murphy E.A., et al. Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes th inactive state of PDGFRβ/B-RAF. PNAS 2010, 107:4299-4304.
35. Nanda A., et al. Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R. Cancer Res. 2004, 64:8507-8511.
36. Nishimura S., et al. Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells. J. Biol. Chem. 2008, 283:11752-11762.
37. Purhonen S., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6620-6625.
38. Rmali K.A., et al. Prognostic values of tumor endothelial markers in patients with colorectal cancer. World J. Gastroenterol. 2005, 11:1283-1286.
39. St.Croix B., et al. Genes expressed in human tumor endothelium. Science 2000, 289:1197-1202.
40. Teicher B.A. A systems approach to cancer therapy. Cancer Metastasis Rev. 1996, 15:247-272.
41. Wang X.-Q., et al. Modulation of tumor endothelial cell marker 7 expression during endothelial cell capillary morphogenesis. Microvasc. Res. 2005, 70:189-197.
42. Weaver A.M. Cortactin and tumor invasiveness. Cancer Lett. 2008, 265:157-166.
43. Yamaji Y., et al. TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 2008, 49:3151-3157.